These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6533469)

  • 1. [Normotensive hypermineralocorticism caused by abusive use of a nasal spray containing 9 alpha-fluoroprednisolone].
    Vincenzi V; Fioroni E; Gambini G; Gradoli C; Benvegnù B; Martella MA; Bartolucci L; Valori C
    Minerva Endocrinol; 1984; 9(3):375-7. PubMed ID: 6533469
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anasarca as the form of presentation of exogenous hypermineralocorticism caused by 9 alpha-fluoroprednisolone].
    de Celis G; Pons JM; Falguera M
    Med Clin (Barc); 1986 Mar; 86(9):392-3. PubMed ID: 3702537
    [No Abstract]   [Full Text] [Related]  

  • 3. [Exogenous hypermineralocorticism caused by a nasal spray containing 9-alpha fluoroprednisolone].
    Virgolini L; Geatti O; Giunta G
    Minerva Cardioangiol; 1984; 32(7-8):473-5. PubMed ID: 6208510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Severe hypopotassemia and rhabdomyolysis in a normotensive subject after use of a nasal spray containing 9-alpha-fluoroprednisolone].
    Wu SC; Secchi MB; Mancarella S; Oltrona L; Bettazzi L; Sale M; Ambrosi B
    Recenti Prog Med; 1989 Apr; 80(4):195-6. PubMed ID: 2762657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A hypokalemic normotensive variant of the syndrome caused by nasal spray containing 9-alpha-fluoroprednisolone].
    Mammarella A; Barlattani M; Bucci O; Fattori F; Filippello CP; Cugini P; Piernatale L; Letizia C; Murano G
    Clin Ter; 1985 Jan; 112(1):9-19. PubMed ID: 4017454
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypermineralocorticism syndromes caused by the topical use of steroids].
    Sánchez Heras M; Pérez García R; Alvarez de Lara A; Valderrábano F
    Med Clin (Barc); 1986 Mar; 86(9):392. PubMed ID: 3702536
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray.
    Vita G; Bartolone S; Santoro M; Toscano A; Carrozza G; Girlanda P; Frisina N
    Clin Neuropathol; 1987; 6(2):80-5. PubMed ID: 3594977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case of pseudohyperaldosteronism caused by 9-alpha-fluoroprednisolone abuse].
    Napolitano C; Frezza F; Salera P; Gattini G; Balzanelli M
    Clin Ter; 1985 Jul; 114(1):63-6. PubMed ID: 4042580
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases].
    Cantello R; Bergamini L; Delsedime M; Durelli L; Troni W; Gilli M; Cocito D
    Minerva Med; 1983 Jun; 74(25):1463-7. PubMed ID: 6856155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertension and hypokalemia caused by a nasal spray containing fluorprednisolone acetate].
    Maiorano G; Loiacono N; Di Bello V; Contursi V; Castelnuovo F; Albano O
    Boll Soc Ital Cardiol; 1981; 26(5):465-71. PubMed ID: 7340877
    [No Abstract]   [Full Text] [Related]  

  • 11. Factitious hypermineralocorticoidism due to transdermal application of a 9-alpha-prednisolone containing ointment.
    Pedrinelli R; Lucarini A; Graziadei L; Taddei S; Salvetti A
    J Endocrinol Invest; 1985 Aug; 8(4):393-4. PubMed ID: 4067210
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypopotassemic myopathy caused by topical administration of 9 alpha fluoroprednisolone].
    Molins A; Alvarez-Sabín J; Montalbán J; Molero J; Alegre J; Codina A
    Neurologia; 1987; 2(5):244-6. PubMed ID: 3274232
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudoaldosteronism due to 9-alpha-fluoroprednisolone creams.
    Morán JM; De Sancho JL; Abaigar P; Amenabar J; Muñiz R; Lampreabe I
    Clin Nephrol; 1984 Dec; 22(6):323-4. PubMed ID: 6525775
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypermineralocorticoidism due to topical application of 9 alpha-fluoroprednisolone.
    Sanchez M; Perez-Garcia R; Lazaro P; López-Gomez JM; Valderrábano F
    Clin Nephrol; 1984 Nov; 22(5):267-8. PubMed ID: 6518677
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypokalemic alkalosis due to 9-alpha-fluoroprednisolone locally applied in pemphigus vulgaris].
    Scarpa C; Gentilli G
    G Ital Dermatol Venereol; 1983; 118(3):179-81. PubMed ID: 6546245
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pseudohyperaldosteronism secondary to oral brushing of 9-alpha-fluoroprednisolone. Presentation of a clinical case].
    Rosselli A; Calacoci S; Regoli G; Turchi A
    G Clin Med; 1985; 66(9-10):359-62. PubMed ID: 3833560
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pseudo-hyperaldosteronism caused by intranasal instillation of 9-alpha-fluoro-prednisolone acetate. Clinico-pathogenetic considerations of a case].
    Camici M; Cini G; Donadio C; Pentimone F
    Minerva Med; 1980 Mar; 71(8):563-6. PubMed ID: 7360385
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arterial hypertension secondary to the application of 9-alpha-fluoroprednisolone ointments].
    Arnal JM; Moneo MI; Loris C
    An Esp Pediatr; 1987 Jan; 26(1):65-6. PubMed ID: 3826948
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypokalaemic hypertension due to a nasal spray containing 9 alpha fluoroprednisolone.
    Zoccali C; Maggiore Q
    Hum Toxicol; 1984 Jun; 3(3):245-7. PubMed ID: 6745965
    [No Abstract]   [Full Text] [Related]  

  • 20. Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.
    Mantero F; Armanini D; Opocher G; Fallo F; Sampieri L; Cuspidi B; Ambrosi C; Faglia G
    Am J Med; 1981 Sep; 71(3):352-7. PubMed ID: 6169277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.